Skip to Content

Current Oncology, Volume 31, Issue 7

2024 July - 43 articles

Cover Story: Chimeric antigen receptor (CAR) T-cell therapy has revolutionised the treatment landscape for patients with multiple myeloma and is likely to be approved in Canada soon. Idecabtagene vicleucel (Ide-cel) (ABECMA®) and Ciltacabtagene autoleucel (Cilta-cel) (CARVYKTI®) are the two CAR T-cell therapy products for patients with relapsed or refractory multiple myeloma commercially available in the US and Europe. Although they have shown unprecedented efficacy, their clinical and logistical limitations must also be acknowledged. Therefore, it is timely that we review the latest evidence on CAR T-cell therapy in multiple myeloma, with a focus on its relevance and impact in the Canadian setting. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (43)

  • Article
  • Open Access
5 Citations
2,799 Views
8 Pages

MRI-Targeted Prostate Fusion Biopsy: What Are We Missing outside the Target? Implications for Treatment Planning

  • Marco Oderda,
  • Alessandro Dematteis,
  • Giorgio Calleris,
  • Romain Diamand,
  • Marco Gatti,
  • Giancarlo Marra,
  • Gilles Adans-Dester,
  • Yazan Al Salhi,
  • Antonio Pastore and
  • Paolo Gontero
  • + 1 author

22 July 2024

Introduction: This study aimed to evaluate the added diagnostic value of systematic biopsies (SBx) after magnetic resonance imaging (MRI)-targeted biopsies (TBx) and the presence of prostate cancer (PCa) outside MRI targets, in a prospective, contemp...

  • Case Report
  • Open Access
1 Citations
1,807 Views
10 Pages

Stereotactic Body Radiation Therapy for Symptomatic Pancreatic Insulinoma: Two-Case Report and Literature Review

  • Agnieszka Namysl-Kaletka,
  • Jerzy Wydmanski,
  • Iwona Debosz-Suwinska,
  • Malgorzata Kaszuba,
  • Dorota Gabrys,
  • Agata Roch-Zniszczol and
  • Daria Handkiewicz-Junak

22 July 2024

Insulinoma is the most common functional neuroendocrine tumor of the pancreas, with the main clinical symptom being hypoglycemia. The standard treatment is surgery, but some patients are not eligible for surgery, while in those operated on, the risk...

  • Article
  • Open Access
3 Citations
4,921 Views
18 Pages

The Effect of Oncology Nurse Navigation on Mental Health in Patients with Cancer in Taiwan: A Randomized Controlled Clinical Trial

  • Wei-Zhen Yu,
  • Hsin-Fang Wang,
  • Yen-Kuang Lin,
  • Yen-Lin Liu,
  • Yun Yen,
  • Jacqueline Whang-Peng,
  • Tsai-Wei Huang and
  • Hsiu-Ju Chang

20 July 2024

In this study, we investigated the prevalence of mental health problems among patients with cancer and whether oncology nurse navigation improved their mental health outcomes and medical experience. In this randomized controlled clinical trial, we re...

  • Article
  • Open Access
2 Citations
6,110 Views
12 Pages

Midazolam Indications and Dosing in Palliative Medicine: Results from a Multinational Survey

  • Morten Tranung,
  • Tora Skeidsvoll Solheim,
  • Erik Torbjørn Løhre,
  • Kristoffer Marsaa,
  • Dagny Faksvåg Haugen,
  • Barry Laird,
  • Morten Thronæs and
  • Michael Due Larsen

19 July 2024

Despite sparse evidence and limited guidance on indications, use, and dosing, midazolam is widely used in palliative care. We aimed to describe and compare the use of midazolam in three different countries to improve clinical practice in palliative c...

  • Article
  • Open Access
3 Citations
2,509 Views
14 Pages

19 July 2024

Objective: Intradural spinal metastases are considered rare. At present, limited information is available on incidence, surgical management, and outcomes. Methods: We conducted a retrospective patient chart review from 2002 to 2024, identifying all p...

  • Conference Report
  • Open Access
2 Citations
3,492 Views
16 Pages

Addressing the Rising Trend in Early-Age-Onset Cancers in Canada

  • Petra Wildgoose,
  • Filomena Servidio-Italiano,
  • Michael J. Raphael,
  • Monika Slovinec D’Angelo,
  • Cassandra Macaulay,
  • Shaqil Kassam,
  • Nancy Nixon,
  • José Perea,
  • Sarah Hamilton and
  • Abha Gupta
  • + 5 authors

19 July 2024

A multi-disciplinary symposium on early-age onset cancer (EAOC) was held in October 2023 to explore challenges experienced by this rapidly growing population. A major outcome of the symposium was recognition of the remarkable similarities of EAOC pat...

  • Article
  • Open Access
2 Citations
2,629 Views
11 Pages

Confirmation of Recurrent Lung Cancer Following Resection Using Liquid Biopsy, a Proof-of-Concept Real-World Study

  • Julia R. Naso,
  • Stephen Yip,
  • Curtis Hughesman,
  • Barb Melosky,
  • Tanner Dowhy,
  • Melissa K. McConechy,
  • John C. English,
  • Penelope M. A. Brasher,
  • James Choi and
  • Anna McGuire
  • + 3 authors

17 July 2024

Appropriate management requires timely and accurate confirmation of non-small cell lung cancer (NSCLC) recurrence in patients who have had curative-intent surgical resection. We assessed the association between circulating tumor DNA (ctDNA) identifie...

  • Article
  • Open Access
6 Citations
3,153 Views
14 Pages

17 July 2024

Regular cervical screening can largely prevent the development of cervical cancer and innovative methods are needed to better engage people in screening. In Ontario, Canada, South Asian women have some of the lowest rates of screening in the province...

  • Communication
  • Open Access
7 Citations
3,352 Views
8 Pages

Ki-67 Labelling Index as a Predictor of Invasive Features in Thyroid Cancer: Retrospective Analysis and Implications

  • Raisa Chowdhury,
  • Raihanah Alsayegh,
  • Véronique-Isabelle Forest,
  • Marc Philippe Pusztaszeri,
  • Sabrina Daniela da Silva,
  • Livia Florianova and
  • Richard J. Payne

17 July 2024

Background: Ki-67 immunostaining is commonly used in neuroendocrine tumors to estimate the proliferative index and for grading. This study investigates its association with the invasiveness of follicular-derived thyroid carcinomas (TCs). Methods: A r...

  • Guidelines
  • Open Access
7 Citations
7,101 Views
8 Pages

Canadian Consensus for Treatment of BRAF V600E Mutated Pediatric and AYA Gliomas

  • Craig Erker,
  • Magimairajan Issai Vanan,
  • Valérie Larouche,
  • Liana Nobre,
  • Chantel Cacciotti,
  • Stéphanie Vairy,
  • Shayna Zelcer,
  • Adam Fleming,
  • Eric Bouffet and
  • Sébastien Perreault
  • + 18 authors

16 July 2024

Background: The treatment of BRAF V600E gliomas with BRAF inhibitors (BRAFis) and MEK inhibitors (MEKis) has been increasingly integrated into clinical practice for pediatric low-grade gliomas (PLGGs) and pediatric high-grade gliomas (HGGs). However,...

  • Case Report
  • Open Access
2 Citations
2,298 Views
7 Pages

14 July 2024

A 48-year-old woman without obvious environmental risk factors was diagnosed with metastatic urothelial carcinoma harboring a mutation in EGFR typical of driver mutations for non-small cell lung cancer. Within a year, her cancer progressed on four st...

  • Opinion
  • Open Access
15 Citations
5,504 Views
12 Pages

12 July 2024

Resilience is defined as the maintenance or relatively quick recovery of mental health during and after adversity. Rather than focusing on psychopathology and its causes, resilience research aims to understand what protective mechanisms shield indivi...

  • Review
  • Open Access
87 Citations
25,453 Views
9 Pages

Temozolomide (TMZ) in the Treatment of Glioblastoma Multiforme—A Literature Review and Clinical Outcomes

  • Marcin Jezierzański,
  • Natalia Nafalska,
  • Małgorzata Stopyra,
  • Tomasz Furgoł,
  • Michał Miciak,
  • Jacek Kabut and
  • Iwona Gisterek-Grocholska

12 July 2024

Glioblastoma multiforme (GBM) is one of the most aggressive primary tumors of the central nervous system. It is associated with a very poor prognosis, with up to half of patients failing to survive the first year after diagnosis. It develops from gli...

  • Communication
  • Open Access
2,634 Views
9 Pages

Is Spirometry a Sufficient Test for Assessing Respiratory Function after Lung Resection?

  • Damian Wnuk,
  • Tomasz Marjański,
  • Bartłomiej Tomasik,
  • Joanna Żuralska-Wnuk and
  • Witold Rzyman

11 July 2024

Background: The prediction of postoperative functional status in non-small cell lung cancer patients based on preoperative assessment of physical and respiratory capacity is inadequate based on recent RCTs. Material and methods: Prospectively collect...

  • Case Report
  • Open Access
1 Citations
2,360 Views
7 Pages

Total Iliocaval Reconstruction in a Complex Palliative Patient with Malignant Inferior Vena Cava Syndrome

  • Jack Lofroth,
  • Amir Pourghadiri,
  • Anastasia Hadjivassiliou,
  • Manraj Heran,
  • Gerald Legiehn,
  • Stephen Ho and
  • Ravjot Dhatt

9 July 2024

Inferior vena cava (IVC) compression secondary to mass effect is accompanied by edema, ascites, back and abdominal pain, and central nervous system symptoms. Most IVC syndrome cases described in the literature focus on the focal treatment of IVC lesi...

  • Case Report
  • Open Access
1 Citations
3,867 Views
10 Pages

Radiosurgically Treated Recurrent Cerebellar Hemangioblastoma: A Case Report and Literature Review

  • François Fabi,
  • Ève Chamberland,
  • Myreille D’Astous,
  • Karine Michaud,
  • Martin Côté and
  • Isabelle Thibault

9 July 2024

Background: Cystic, sporadic hemangioblastomas (HBLs) represent a unique, therapeutically challenging subset of central nervous system tumors, mainly due to their unpredictable growth patterns and potential for symptomatic progression. This study aim...

  • Review
  • Open Access
3 Citations
8,188 Views
19 Pages

6 July 2024

Multiple myeloma (MM) is an incurable plasma cell malignancy. In the context of the current standard of care therapies in Canada, outcomes among patients with relapsed/refractory multiple myeloma (RRMM), particularly those with triple-class (or more)...

  • Article
  • Open Access
1 Citations
3,899 Views
10 Pages

6 July 2024

(1) Purpose: The purpose of this study was to describe the outcomes of diagnostic breast imaging and the incidence of delayed breast cancer diagnosis in the study population. (2) Methods: We collected the outcome data from diagnostic mammograms and/o...

  • Review
  • Open Access
11 Citations
10,520 Views
16 Pages

Endoscopic Grading and Sampling of Gastric Precancerous Lesions: A Comprehensive Literature Review

  • Georgios Tziatzios,
  • Dimitrios Ι. Ziogas,
  • Paraskevas Gkolfakis,
  • Vasilios Papadopoulos,
  • Apostolis Papaefthymiou,
  • Nikoletta Mathou,
  • Athanasios Giannakopoulos,
  • Gerasimos Gerasimatos,
  • Konstantina D. Paraskeva and
  • Konstantinos Triantafyllou

5 July 2024

Gastric cancer remains a disease with an ominous prognosis, while early gastric cancer has a good-to-excellent prognosis, with 5-year survival rates of up to 92.6% after successful endoscopic resection. In this context, the accurate identification of...

  • Review
  • Open Access
2,212 Views
15 Pages

Cancer Prevention and Cultural Continuity for Métis Peoples in Canada: A Scoping Review

  • Maria Diaz Vega,
  • José Diego Marques Santos,
  • Stephanie Witham,
  • Marg Friesen,
  • Tegan Brock,
  • Sheila Laroque,
  • Jennifer Sedgewick,
  • Tracey Carr and
  • Gary Groot

5 July 2024

The purpose of this scoping review was to map the literature on the relationship between cultural continuity and health among Métis people as well as how this knowledge could be translated into cancer prevention initiatives. We included any M&...

  • Article
  • Open Access
1,709 Views
13 Pages

Critical Issues for Patients and Caregivers in Neuro-Oncology during the COVID-19 Pandemic: What We Have Learnt from an Observational Study

  • Elena Anghileri,
  • Irene Tramacere,
  • Sara Morlino,
  • Catia Leuzzi,
  • Lorena Pareja Gutierrez,
  • Saba Motta,
  • Antonio Silvani,
  • Anna Amato and
  • Francesca Romana Berrini

4 July 2024

Objective: The COVID-19 pandemic affected neuro-oncological patients and their caregivers regarding tumor care and emotional functioning, including Quality of Life (QoL). This study aimed to understand how COVID-19 affected their psychological state...

  • Article
  • Open Access
2,301 Views
10 Pages

4 July 2024

Cost-effectiveness analyses are required for therapies within Canada’s universal healthcare system, leading to delays relative to U.S. healthcare. Patients with Hodgkin lymphoma (HL) generally have an excellent prognosis, but those who relapse...

  • Review
  • Open Access
18 Citations
11,431 Views
15 Pages

Current Advances in Radioactive Iodine-Refractory Differentiated Thyroid Cancer

  • Fabio Volpe,
  • Carmela Nappi,
  • Emilia Zampella,
  • Erica Di Donna,
  • Simone Maurea,
  • Alberto Cuocolo and
  • Michele Klain

3 July 2024

Background: Differentiated thyroid cancer (DTC) patients have an outstanding overall long-term survival rate, and certain subsets of DTC patients have a very high likelihood of disease recurrence. Radioactive iodine (RAI) therapy is a cornerstone in...

  • Article
  • Open Access
1 Citations
3,115 Views
15 Pages

2 July 2024

Introduction: Right hemicolectomy (RHC) remains the treatment standard for goblet cell adenocarcinoma (GCA), despite limited evidence supporting survival benefit. This study aims to explore factors influencing surgical management and survival outcome...

  • Article
  • Open Access
20 Citations
4,017 Views
10 Pages

Quality of ChatGPT-Generated Therapy Recommendations for Breast Cancer Treatment in Gynecology

  • Jan Lennart Stalp,
  • Agnieszka Denecke,
  • Matthias Jentschke,
  • Peter Hillemanns and
  • Rüdiger Klapdor

1 July 2024

Introduction: Artificial intelligence (AI) is revolutionizing medical workflows, with self-learning systems like ChatGPT showing promise in therapy recommendations. Our study evaluated ChatGPT’s performance in suggesting treatments for 30 breas...

  • Review
  • Open Access
44 Citations
10,527 Views
19 Pages

The Complex Tumor Microenvironment in Ovarian Cancer: Therapeutic Challenges and Opportunities

  • Bianca Garlisi,
  • Sylvia Lauks,
  • Caroline Aitken,
  • Leslie M. Ogilvie,
  • Cielle Lockington,
  • Duncan Petrik,
  • Jan Soeren Eichhorn and
  • Jim Petrik

1 July 2024

The tumor microenvironment (TME) in ovarian cancer (OC) has much greater complexity than previously understood. In response to aggressive pro-angiogenic stimulus, blood vessels form rapidly and are dysfunctional, resulting in poor perfusion, tissue h...

  • Article
  • Open Access
5 Citations
2,564 Views
11 Pages

BRCA Testing for Patients Treated in Italy: A National Survey of Breast Centers Associated with Senonetwork

  • Corrado Tinterri,
  • Damiano Gentile,
  • Francesco Caruso,
  • Laura Cortesi,
  • Michelino De Laurentiis,
  • Lucio Fortunato,
  • Donatella Santini,
  • Daniela Turchetti,
  • Alberta Ferrari and
  • Senonetwork Italia Breast Centre Responders
  • + 1 author

30 June 2024

Background: Breast units (BUs) provide breast cancer (BC) care, including prevention, treatment, and genetic assessment. Genetic research has highlighted BRCA1/2 mutations as key hereditary BC risk factors. BRCA testing is crucial for personalized tr...

  • Case Report
  • Open Access
2,608 Views
7 Pages

30 June 2024

The application of adjuvant treatment has significantly enhanced the survival of patients with resectable non-small cell lung cancer (NSCLC) carrying driver gene mutations. However, adjuvant-targeted therapy remains controversial for some NSCLC patie...

  • Article
  • Open Access
1 Citations
1,909 Views
10 Pages

Disparities in Outcomes following Resection of Locally Advanced Rectal Cancer

  • William Y. Luo,
  • Dimitrios N. Varvoglis,
  • Chris B. Agala,
  • Lydia H. Comer,
  • Pragna Shetty,
  • Trevor Wood,
  • Muneera R. Kapadia,
  • Jonathan M. Stem and
  • José G. Guillem

30 June 2024

Surgical margins following rectal cancer resection impact oncologic outcomes. We examined the relationship between margin status and race, ethnicity, region of care, and facility type. Patients undergoing resection of a stage II–III locally adv...

  • Review
  • Open Access
6 Citations
3,419 Views
15 Pages

Improving Care for Older Adults with Cancer in Canada: A Call to Action

  • Sarah Cook,
  • Shabbir Alibhai,
  • Rajin Mehta,
  • Marie-France Savard,
  • Caroline Mariano,
  • Dominique LeBlanc,
  • Danielle Desautels,
  • Rossanna Pezo,
  • Xiaofu Zhu and
  • Tina Hsu
  • + 1 author

30 June 2024

Most patients diagnosed with and dying from cancer in Canada are older adults, with aging contributing to the large projected growth in cancer incidence. Older adults with cancer have unique needs, and on a global scale increasing efforts have been m...

  • Review
  • Open Access
1 Citations
6,759 Views
12 Pages

Shifting Paradigms in TNBC Treatment: Emerging Alternatives to Capecitabine in the Post-Neoadjuvant Setting

  • Halima Abahssain,
  • Amine Souadka,
  • Rania Alem,
  • Matteo Santoni,
  • Nicola Battelli,
  • Eric Amela,
  • Antoine Lemaire,
  • Joseph Rodriguez and
  • Hassan Errihani

30 June 2024

Background: Triple-negative breast cancer (TNBC) remains a clinically challenging subtype due to its aggressive nature and limited treatment options post-neoadjuvant failure. Historically, capecitabine has been the cornerstone of adjuvant therapy for...

  • Article
  • Open Access
5,052 Views
13 Pages

Adjuvant Treatment of Stage I–II Serous Endometrial Cancer: A Single Institution 20-Year Experience

  • Aquila Akingbade,
  • François Fabi,
  • Rodrigo Cartes,
  • James Tsui and
  • Joanne Alfieri

29 June 2024

Background: Serous endometrial carcinoma (SEC) is a high-risk subtype of endometrial cancer. The effectiveness of multiple adjuvant therapies, namely chemotherapy (CT), radiotherapy (RT), and sequential/concurrent chemotherapy with radiotherapy (CRT)...

  • Project Report
  • Open Access
2 Citations
3,657 Views
6 Pages

Leveraging Nursing Assessment for Early Identification of Post Operative Gastrointestinal Dysfunction (POGD) in Patients Undergoing Colorectal Surgery

  • Tessy Siby,
  • Alice Shajimon,
  • Daniel Mullen,
  • Shahnaz Gillani,
  • Jeffrey R. Ong,
  • Nikki E. Dinkins,
  • Brittany Kruse,
  • Carla Patel,
  • Craig Messick and
  • Vijaya Gottumukkala
  • + 2 authors

29 June 2024

Background: Postoperative gastrointestinal dysfunction (POGD) remains a common morbidity after gastrointestinal surgery. POGD is associated with delayed hospital recovery, increased length of stay, poor patient satisfaction and experience, and increa...

  • Review
  • Open Access
4 Citations
2,161 Views
14 Pages

What Is Ailing Oncology Clinical Trials? Can We Fix Them?

  • Abhenil Mittal,
  • Sara Moore,
  • Vishal Navani,
  • Di Maria Jiang,
  • David J. Stewart,
  • Geoffrey Liu and
  • Paul Wheatley-Price

28 June 2024

Evidence from phase three clinical trials helps shape clinical practice. However, a very small minority of patients with cancer participate in clinical trials and many trials are not completed on time due to slow accrual. Issues with restrictive elig...

  • Article
  • Open Access
1,728 Views
25 Pages

To Reconstruct or Not to Reconstruct: Piloting a Vietnamese and Arabic Breast Reconstruction Decision Aid in Australia

  • Patsy S. Soon,
  • Khouloud Kamalmaz,
  • Verena S. Wu,
  • Neda Karimi,
  • Martha Gerges,
  • Kerry A. Sherman and
  • Afaf Girgis

28 June 2024

Currently, there are no resources to support culturally and linguistically diverse (CALD) women with breast cancer to make decisions about undergoing breast reconstruction (BR). This study evaluated the usability and acceptability of decision aids (D...

  • Article
  • Open Access
1 Citations
2,179 Views
15 Pages

Navigation-Based Telehealth Informed Decision-Making for Prostate Cancer Screening in Black Men

  • Djibril M. Ba,
  • Chrispin Kayembe,
  • Joe Littlejohn,
  • Lauren J. Van Scoy,
  • Erika VanDyke,
  • James Williams,
  • Avnish Katoch,
  • Neil C. Shook,
  • Yue Zhang and
  • Joshua E. Muscat
  • + 2 authors

28 June 2024

The rapid increase in telehealth has the potential to bring informed decision-making for prostate cancer screening (PCS) at the population level to high-risk individuals. We utilized a global technology platform of electronic health records data repo...

  • Article
  • Open Access
3 Citations
2,553 Views
8 Pages

27 June 2024

Background: In current clinical practice, intensity-modulated proton therapy (IMPT) head and neck cancer (HNC) plans are generated using a constant relative biological effectiveness (cRBE) of 1.1. The primary goal of this study was to explore the dos...

  • Case Report
  • Open Access
5 Citations
6,889 Views
8 Pages

27 June 2024

Small-cell lung cancer (SCLC) remains a disease with poor prognosis, particularly in extensive-stage SCLC (ES-SCLC). Current standard-of-care treatment includes chemotherapy with platinum agents and etoposide plus immunotherapy with atezolizumab or d...

  • Review
  • Open Access
4 Citations
5,283 Views
13 Pages

26 June 2024

For patients diagnosed with localized prostate cancer, there are multiple treatment options available. The traditional treatment modalities include radical prostatectomy and radiotherapy. Nevertheless, focal therapy, including high-intensity focused...

  • Article
  • Open Access
7 Citations
5,500 Views
12 Pages

Long-Term Outcomes following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Origin

  • Kadhim Taqi,
  • Jay Lee,
  • Scott Hurton,
  • Cecily Stockley,
  • Lloyd Mack,
  • Justin Rivard,
  • Walley Temple and
  • Antoine Bouchard-Fortier

25 June 2024

Background: Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) is a major treatment of colorectal peritoneal carcinomatosis (CPC). The aim was to determine the disease-free survival (DFS) and overall survival...

  • Article
  • Open Access
2,216 Views
14 Pages

Nonspecific Signs and/or Symptoms of Cancer: A Retrospective, Observational Analysis from a Secondary Care, US Community Oncology Dataset

  • Christopher B. Benton,
  • Ding He,
  • Karen Todoroff,
  • Marie V. Coignet,
  • Ying Luan,
  • Jason C. Wong,
  • Kathryn N. Kurtzman and
  • Ira Zackon

25 June 2024

To help determine the unmet need for improved diagnostic tools to evaluate patients with nonspecific signs and/or symptoms (NSSS) and suspicion of cancer, we examined patient characteristics, diagnostic journey, and cancer incidence of patients with...

  • Article
  • Open Access
3 Citations
3,302 Views
13 Pages

22 June 2024

Current prediction models for patients with ostosarcoma are restricted to predictions from a single, static point in time, such as diagnosis or surgery. These approaches discard information which becomes available during follow-up and may have an imp...

  • Review
  • Open Access
2 Citations
4,369 Views
15 Pages

Integrating Molecular Insights into Biliary Tract Cancer Management: A Review of Personalized Therapeutic Strategies

  • Mar Ros-Buxó,
  • Ezequiel Mauro,
  • Tamara Sauri,
  • Gemma Iserte,
  • Carla Fuster-Anglada,
  • Alba Díaz,
  • Laura Sererols-Viñas,
  • Silvia Affo and
  • Alejandro Forner

21 June 2024

Biliary tract cancers (BTCs) are rare and aggressive malignancies with an increasing incidence and poor prognosis. The standard systemic treatment for BTCs has evolved to include immune checkpoint inhibitors associated with gemcitabine–cisplati...

XFacebookLinkedIn
Curr. Oncol. - ISSN 1718-7729